Choroba wątroby związana z alkoholem – Zapobieganie i profilaktyka

Choroba wątroby związana z alkoholem
Zapobieganie i profilaktyka

Choroba wątroby związana z alkoholem (ALD) stanowi istotne wyzwanie zdrowotne, będąc główną przyczyną zachorowalności i śmiertelności. Kluczowym elementem profilaktyki jest ograniczenie spożycia alkoholu do maksymalnie 14 jednostek tygodniowo, rozłożonych na co najmniej 3 dni, z zaleceniem dni bezalkoholowych. Ryzykowne picie definiuje się jako spożycie ≥5 napojów u mężczyzn lub ≥4 u kobiet przy jednej okazji. Na poziomie populacyjnym najskuteczniejsze są interwencje obejmujące podwyższenie podatków, minimalną cenę jednostkową alkoholu, ograniczenia w dostępności oraz zakaz reklamy. Wczesne wykrycie nadmiernego spożycia alkoholu i ALD poprzez rutynowe badania przesiewowe (np. AUDIT) oraz krótkie interwencje w POZ są rekomendowane przez USPSTF i AASLD. Kompleksowe leczenie obejmuje terapię poznawczo-behawioralną, farmakoterapię (naltrekson, akamprozat, baklofen) dostosowaną do stanu wątroby oraz wsparcie psychospołeczne.

Choroba wątroby związana z alkoholem – Profilaktyka i zapobieganie
Profilaktyka pierwotna – zapobieganie rozwojowi choroby wątroby związanej z alkoholem

Ograniczenie spożycia alkoholu
Polityka zdrowia publicznego
Edukacja i zwiększanie świadomości

Profilaktyka wtórna – wczesne wykrywanie i interwencja

Badania przesiewowe i wczesne rozpoznanie
Interwencje dla osób z grupy ryzyka
Profilaktyka infekcji wirusowych

Profilaktyka trzeciorzędowa – postępowanie u pacjentów z rozpoznaną chorobą

Abstynencja od alkoholu
Farmakoterapia wspierająca abstynencję
Zintegrowana opieka i wsparcie psychospołeczne
Wsparcie żywieniowe i modyfikacja stylu życia
Transplantacja wątroby

Zapobieganie nawrotom po przeszczepie wątroby
Bezpieczeństwo stosowania leków u pacjentów z ALD
Podsumowanie działań profilaktycznych

Kolejne rozdziały

Choroba wątroby związana z alkoholem – Profilaktyka i zapobieganie

Choroba wątroby związana z alkoholem (ALD) stanowi poważny problem zdrowia publicznego na całym świecie. Jest to główna przyczyna zachorowalności, utraty lat życia skorygowanych o niepełnosprawność oraz śmiertelności. Obciążenie systemu opieki zdrowotnej kosztami związanymi z ALD jest w dużej mierze możliwe do uniknięcia, ponieważ spożycie alkoholu jest najważniejszym czynnikiem determinującym ryzyko i ciężkość choroby¹. Skuteczne strategie profilaktyczne oraz metody zapobiegania są niezbędne do zmniejszenia obciążenia związanego z tą chorobą, zarówno na poziomie indywidualnym, jak i populacyjnym.

Profilaktyka pierwotna – zapobieganie rozwojowi choroby wątroby związanej z alkoholem

Ograniczenie spożycia alkoholu

Najbardziej skutecznym sposobem zapobiegania chorobie wątroby związanej z alkoholem jest całkowite zaprzestanie spożywania alkoholu lub przestrzeganie zalecanych limitów¹. Zgodnie z aktualnymi wytycznymi zdrowotnymi zaleca się, aby:

Mężczyźni i kobiety nie powinni regularnie spożywać więcej niż 14 jednostek alkoholu tygodniowo¹
Spożycie alkoholu powinno być rozłożone na 3 lub więcej dni, jeśli pije się 14 jednostek tygodniowo¹
Zaleca się wprowadzenie kilku dni bez alkoholu w każdym tygodniu¹

Wytyczne amerykańskiego Departamentu Zdrowia i Usług Społecznych zalecają, aby kobiety nie spożywały więcej niż 1 napoju alkoholowego dziennie, a mężczyźni nie więcej niż 2 napoje dziennie¹. Według Narodowego Instytutu ds. Nadużywania Alkoholu i Alkoholizmu (NIAAA), za picie ryzykowne uznaje się spożycie 5 lub więcej napojów alkoholowych przez mężczyzn lub 4 lub więcej napojów przez kobiety przy jednej okazji, co najmniej 1 dzień w ciągu ostatniego miesiąca¹.

Polityka zdrowia publicznego

Od lat 90. XX wieku główne instytucje zdrowia publicznego i rządy opracowały różnorodne polityki mające na celu zmniejszenie szkód powodowanych przez nadmierne spożywanie alkoholu. Strategie te obejmują wiele czynników, od ustalania cen i opodatkowania po regulację reklam¹. Środki skoncentrowane na opodatkowaniu i regulacji cen okazały się najbardziej skuteczne w zmniejszaniu śmiertelności związanej z alkoholem¹.

Do najskuteczniejszych interwencji na poziomie populacyjnym należą:

Zwiększenie podatków na napoje alkoholowe i wprowadzenie minimalnej ceny jednostkowej (MUP) – oba rozwiązania mają udowodniony wpływ na zmniejszenie obciążenia ALD¹
Ograniczenie fizycznego dostępu do alkoholu poprzez ustawodawstwo dotyczące godzin i dni sprzedaży oraz gęstości punktów sprzedaży alkoholu²
Regulacja reklamy i promocji napojów alkoholowych – najnowsze wytyczne Europejskiego Towarzystwa Badań nad Wątrobą (EASL) dotyczące ALD zalecają zakaz reklamy i marketingu alkoholu¹

Podatkowanie i regulacja cen są najbardziej skutecznymi środkami zmniejszającymi śmiertelność związaną z alkoholem, chociaż efekt różni się w zależności od kraju². Interwencje na poziomie całej populacji, takie jak minimalna cena jednostkowa alkoholu, ograniczenie lub zakaz reklamy alkoholu, mają na celu zmniejszenie dostępności alkoholu na poziomie populacyjnym².

Edukacja i zwiększanie świadomości

Edukacja społeczeństwa na temat ryzyka związanego ze spożywaniem alkoholu jest kluczowym elementem zapobiegania ALD. Metody edukacyjne mogą obejmować:

Jasne oznakowanie produktów alkoholowych, podobne do informacji żywieniowych na żywności, co może pomóc konsumentom podejmować bardziej świadome decyzje dotyczące spożywania alkoholu¹
Programy edukacyjne dotyczące zagrożeń związanych z nadużywaniem alkoholu¹
Otwarta rozmowa z lekarzem o spożyciu alkoholu, który może doradzić bezpieczne ilości alkoholu¹²

Gdy poziom edukacji i świadomości zagrożeń związanych z nadużywaniem alkoholu wzrasta, jego spożycie zazwyczaj spada¹. Dlatego nacisk na edukację i leczenie jest niezbędny w profilaktyce ALD.

Profilaktyka wtórna – wczesne wykrywanie i interwencja

Badania przesiewowe i wczesne rozpoznanie

Wczesne wykrycie nadmiernego spożycia alkoholu i ALD jest kluczowe dla efektywnej interwencji. Zgodnie z zaleceniami:

Amerykańska Grupa Zadaniowa ds. Usług Profilaktycznych (USPSTF) zaleca rutynowe badania przesiewowe w kierunku niezdrowego spożywania alkoholu wraz z krótką interwencją w ramach podstawowej opieki zdrowotnej¹
Amerykańskie Towarzystwo Badań nad Chorobami Wątroby (AASLD) zaleca, aby wszyscy pacjenci w poradniach podstawowej opieki zdrowotnej i gastrologii/hepatologii, jak również pacjenci oddziałów ratunkowych i szpitali byli rutynowo badani pod kątem spożycia alkoholu przy użyciu zwalidowanych kwestionariuszy¹²
AASLD zaleca stosowanie kwestionariusza Alcohol Use Disorders Inventory Test (AUDIT) w przypadku podejrzenia nadmiernego spożycia alkoholu¹

Pacjentom zaangażowanym w ryzykowne picie alkoholu (tj. intensywne lub kompulsywne picie) należy zaoferować krótką interwencję, farmakoterapię i skierowanie na leczenie¹². Badania przesiewowe mogą również obejmować regularne badania funkcji wątroby, co umożliwia wczesne wykrycie uszkodzenia wątroby¹.

Interwencje dla osób z grupy ryzyka

Osoby pijące nadmiernie alkohol powinny otrzymać odpowiednie wsparcie w celu zmiany swoich nawyków picia:

Krótkie interwencje, wywiad motywacyjny, terapia poznawczo-behawioralna (CBT) lub terapia wzmacniania motywacji mogą być stosowane w celu pomocy w ograniczeniu spożycia alkoholu¹
CBT ma najbardziej konsekwentne dowody na zwiększenie abstynencji u pacjentów z ALD, chociaż dane są ograniczone¹
Połączenie kompleksowej opieki medycznej i interwencji psychospołecznych z większym prawdopodobieństwem prowadzi do abstynencji, a zintegrowane podejścia do opieki są związane z lepszymi wynikami¹

Badanie biomarkerów spożycia alkoholu może pomóc w diagnostyce i obserwacji ALD, dostarczając obiektywnych informacji na temat spożycia alkoholu, oprócz samooceny¹.

Profilaktyka infekcji wirusowych

Infekcje wirusowe, szczególnie wirusowe zapalenie wątroby, mogą znacznie zwiększyć ryzyko uszkodzenia wątroby u osób spożywających alkohol:

Zaleca się szczepienia przeciwko wirusowemu zapaleniu wątroby typu A i B u pacjentów z przewlekłą chorobą wątroby¹
Wirusowe zapalenie wątroby typu C i alkohol działają synergistycznie w przyspieszaniu rozwoju marskości wątroby; dlatego pacjenci z zakażeniem HCV powinni całkowicie powstrzymać się od spożywania alkoholu¹
Zaleca się również szczepienia przeciwko grypie i pneumokokowemu zapaleniu płuc¹²

Usługa rutynowych szczepień powinna być traktowana jako priorytetowa usługa zdrowotna, szczególnie w kontekście możliwych zakłóceń w systemie opieki zdrowotnej¹.

Profilaktyka trzeciorzędowa – postępowanie u pacjentów z rozpoznaną chorobą

Abstynencja od alkoholu

Abstynencja od alkoholu jest podstawą leczenia i powinna być zalecana wszystkim pacjentom z ALD¹. Jest to najważniejszy krok w zapobieganiu dalszemu uszkodzeniu wątroby:

U pacjentów z ALD, bez względu na stadium choroby, najlepszym leczeniem jest abstynencja od alkoholu¹²
W przypadku stłuszczenia wątroby związanego z alkoholem i zapalenia wątroby, abstynencja może odwrócić uszkodzenia¹²
U pacjentów z bardziej zaawansowaną formą ALD (alkoholowe zapalenie wątroby lub marskość) zalecana jest dożywotnia abstynencja¹²
Zaprzestanie picia alkoholu to jedyny sposób na zapobieżenie pogorszeniu się uszkodzenia wątroby i potencjalnie uniknięcie śmierci z powodu choroby wątroby¹²

U pacjentów z wyrównaną i niewyrównaną marskością wątroby abstynencja zmniejsza ryzyko dekompensacji wątroby i zgonu¹. Bez względu na stadium ALD, spożywanie alkoholu całkowicie komplikuje leczenie, a w przypadku marskości alkoholowej lub alkoholowego zapalenia wątroby, jeśli pacjent nie przestanie pić, żadne leczenie medyczne ani chirurgiczne nie może zapobiec niewydolności wątroby¹.

Farmakoterapia wspierająca abstynencję

Pacjenci z ALD często potrzebują farmakoterapii wspierającej abstynencję od alkoholu:

Po zaprzestaniu picia można zastosować dodatkowe leczenie, aby pomóc zapewnić, że pacjent nie zacznie ponownie pić¹
Jeśli sama terapia psychologiczna nie jest skuteczna, pacjent może również potrzebować leków ułatwiających abstynencję od alkoholu, takich jak: akamprozat, disulfiram, naltrekson¹
Leki pierwszego rzutu w leczeniu zaburzeń związanych ze spożywaniem alkoholu (AUD) to naltrekson i akamprozat¹

Wybór farmakoterapii powinien uwzględniać stan wątroby pacjenta:

Baklofen, mimo że nie jest zatwierdzony przez FDA do leczenia AUD, jest najlepiej przebadanym lekiem w leczeniu AUD u pacjentów z przewlekłą chorobą wątroby i wykazał skuteczność u pacjentów z marskością wątroby¹²
Akamprozat jest metabolizowany przez nerki i był skuteczny w leczeniu AUD w jednym badaniu u pacjentów z marskością wątroby¹
Naltrekson nie jest dobrze przebadany u pacjentów z przewlekłą chorobą wątroby, ale można go rozważyć u pacjentów z wyrównaną chorobą¹
Disulfiram należy unikać u pacjentów z przewlekłą chorobą wątroby ze względu na ryzyko hepatotoksyczności¹

Warto zauważyć, że większość dowodów dotyczących farmakologicznego leczenia AUD pochodzi z badań przeprowadzonych u pacjentów bez znanej choroby wątroby, dlatego profil bezpieczeństwa i farmakodynamika niektórych z tych leków nie są dobrze poznane u pacjentów z marskością wątroby¹.

Zintegrowana opieka i wsparcie psychospołeczne

Kompleksowe podejście do leczenia ALD powinno obejmować opiekę medyczną, wsparcie psychologiczne i społeczne:

Wielu pacjentów z uzależnieniem od alkoholu uznaje za pomocne uczestnictwo w grupach samopomocowych wspierających abstynencję¹²
Leczenie zaburzeń związanych ze spożywaniem alkoholu jest najważniejszym elementem po zaprzestaniu picia alkoholu¹
Zarządzanie objawami odstawienia alkoholu jest kluczowym aspektem utrzymania abstynencji; odstawienie alkoholu może być niebezpieczne i ważna jest interwencja medyczna i wsparcie podczas odstawienia¹
Zapobieganie nawrotom jest istotną częścią utrzymania długoterminowej abstynencji i ograniczenia ryzyka progresji ALD¹

Leczenie choroby wątroby związanej z alkoholem wymaga podejścia multidyscyplinarnego. Zespoły medyczne powinny obejmować ekspertów w dziedzinie chorób wątroby, medycyny uzależnień/psychiatrii, żywienia i transplantacji wątroby, aby zapewnić kompleksowy, zindywidualizowany i oparty na dowodach plan leczenia dla każdego pacjenta na dowolnym etapie choroby wątroby związanej z alkoholem¹.

Wsparcie żywieniowe i modyfikacja stylu życia

Odpowiednie odżywianie i zdrowy styl życia są istotnymi elementami postępowania u pacjentów z ALD:

Lekarz pierwszego kontaktu może doradzić odpowiednią dietę lub w niektórych przypadkach skierować do dietetyka¹²
Unikanie słonych potraw i niedodawanie soli do spożywanych pokarmów może zmniejszyć ryzyko rozwoju obrzęku nóg, stóp i brzucha (brzucha) spowodowanego nagromadzeniem płynów¹
Zalecane jest dzienne spożycie energii na poziomie 35-40 kcal na kg masy ciała oraz dzienne spożycie białka na poziomie 1,2-1,5 g na kg masy ciała¹
Klinicyści zalecają, aby wszyscy pacjenci z chorobą alkoholową poddawani leczeniu otrzymywali 50 miligramów tiaminy dziennie¹

Przewlekłe spożywanie alkoholu z ALD lub bez niego może prowadzić do niedożywienia, które wiąże się z gorszymi wynikami w przewlekłej chorobie wątroby. Dlatego pacjenci z ALD powinni być regularnie oceniani pod kątem niedożywienia przez dietetyka, a w razie potrzeby należy przepisać suplementację żywieniową w postaci kalorii, białka i witamin¹.

Transplantacja wątroby

Dla pacjentów z zaawansowaną marskością wątroby, przeszczep wątroby może być jedyną opcją ratującą życie:

Przeszczep wątroby może być rozważany, jeśli pacjent zobowiąże się do niepicia alkoholu przez resztę życia¹
Abstynencja od alkoholu jest wymagana do umieszczenia na liście oczekujących na przeszczep wątroby w większości ośrodków transplantacyjnych¹
Aby być branym pod uwagę do przeszczepu wątroby, pacjenci muszą pozostać abstynentami od alkoholu przed operacją przeszczepu; celem jest zapewnienie, że pacjenci są w stanie utrzymać abstynencję i prawdopodobnie pozostaną abstynentami po operacji przeszczepu¹

Rośnie poparcie dla wczesnego przeszczepu wątroby u niektórych pacjentów z ciężkim alkoholowym zapaleniem wątroby, zamiast wymagania sześciu miesięcy abstynencji od alkoholu i zaangażowania w poradnictwo dotyczące zaprzestania picia alkoholu¹. Jednak arbitralny okres abstynencji nie powinien być warunkiem wstępnym kwalifikacji do przeszczepu, a nawrót nie powinien automatycznie dyskwalifikować pacjenta z otrzymania przeszczepu wątroby¹.

Zapobieganie nawrotom po przeszczepie wątroby

Zapobieganie nawrotom picia alkoholu po przeszczepie wątroby jest kluczowe dla powodzenia leczenia:

Multidyscyplinarna opieka jest ważna dla zapobiegania nawrotom alkoholu po przeszczepie¹
Klinika Long-term Individualized Follow-up after Transplant (LIFT) w Massachusetts General Hospital to przykład multidyscyplinarnego programu obejmującego hepatologa, psychiatrę, pracownika socjalnego i menedżera przypadku, mającego na celu pomoc w zapobieganiu i leczeniu nawrotów alkoholu u pacjentów wysokiego ryzyka po przeszczepie wątroby¹
Ważne jest, aby być świadomym możliwości nawrotu u pacjentów uznawanych za osoby o niskim ryzyku¹

Program LIFT został rozszerzony, aby obejmować wszystkich pacjentów, u których alkohol jest czynnikiem przyczyniającym się do choroby wątroby. Pozwala to na dostosowanie intensywności obserwacji do poziomu ryzyka: „Jeśli stwierdzimy, że mają bardzo niskie ryzyko, możemy widywać ich w dłuższych odstępach czasu, ale jeśli znajdziemy jakiekolwiek czynniki wysokiego ryzyka u tych pacjentów, zaczynamy bardzo dokładnie ich obserwować”¹.

Bezpieczeństwo stosowania leków u pacjentów z ALD

Pacjenci z chorobą wątroby związaną z alkoholem często przyjmują leki w celu leczenia powikłań choroby wątroby i chorób współistniejących. Istotne jest odpowiednie zarządzanie farmakoterapią, aby zminimalizować ryzyko szkód związanych z lekami¹:

Regularna ocena leków jest niezbędna, aby zapewnić ich ciągłą adekwatność i bezpieczeństwo¹
Lekarze podstawowej opieki zdrowotnej są idealnie przygotowani do poprawy bezpieczeństwa stosowania leków poprzez przegląd i monitorowanie leków pacjenta oraz ograniczenie stosowania potencjalnie nieodpowiednich leków¹
Należy unikać leków hepatotoksycznych, szczególnie niesteroidowych leków przeciwzapalnych¹
Należy sprawdzać przed mieszaniem leków i alkoholu – zapytać pracownika służby zdrowia, czy bezpieczne jest picie alkoholu podczas przyjmowania przepisanych leków¹

Lekarze, pielęgniarki i farmaceuci w podstawowej opiece zdrowotnej odgrywają ważną rolę w leczeniu pacjentów z chorobą wątroby związaną z alkoholem. Oprócz wspierania abstynencji, optymalizacja stosowania leków jest niezbędna do poprawy wyników i zminimalizowania szkód¹.

Podsumowanie działań profilaktycznych

Zapobieganie i leczenie choroby wątroby związanej z alkoholem wymaga wielopoziomowego podejścia, obejmującego:

Profilaktykę pierwotną – edukację, politykę zdrowia publicznego i ograniczenie spożycia alkoholu¹
Profilaktykę wtórną – wczesne wykrywanie i interwencję u osób z grupy ryzyka¹
Profilaktykę trzeciorzędową – strategie mające na celu zarządzanie i minimalizowanie wpływu choroby po wystąpieniu uszkodzenia wątroby¹

Kluczową rolę odgrywają również klinicyści w promowaniu polityki zdrowia publicznego, powszechnych badań przesiewowych w kierunku zaburzeń związanych ze spożywaniem alkoholu (AUD) i ALD oraz integracji opieki nad wątrobą z opieką nad uzależnieniami u pacjentów z ALD¹.

Wczesna interwencja może zmniejszyć ryzyko dalszego uszkodzenia wątroby i drastycznie poprawić wyniki leczenia pacjentów¹. Na każdym etapie choroby wątroby związanej z alkoholem, abstynencja od alkoholu oferuje najlepsze wyniki¹.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1
https://journals.lww.com/ajg/abstract/9900/prevention_of_alcohol_associated_liver_disease.1651.aspx
Alcohol-associated liver disease (ALD) is the leading cause of morbidity, disease adjusted life-years lost, and mortality worldwide. The significant burden and cost to the healthcare systems from ALD is largely preventable, given that alcohol use is the most important determinant of risk and severity of ALD. […] In this article, we will review the emerging evidence for public health policies (minimum unit price of alcohol, limiting or banning alcohol advertising), aiming to reduce the availability of alcohol at the population level (primary prevention), preventing ALD especially advanced form of cirrhosis in at risk individuals (secondary prevention), and improving liver outcomes and long-term survival in patients with advanced ALD of cirrhosis and / or alcohol-associated hepatitis (tertiary prevention). […] We will highlight the critical role of clinicians in promoting the public health policies, widespread screening for AUD and for ALD, and integrating liver with addiction care for patients with ALD.
#1
https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/
The most effective way to prevent ARLD is to stop drinking alcohol or stick to the recommended limits: […] men and women are advised not to regularly drink more than 14 units a week […] spread your drinking over 3 days or more if you drink as much as 14 units a week […] if you want to cut down, try to have several drink-free days each week. […] Even if you have been a heavy drinker for many years, reducing or stopping your alcohol intake will have important short-term and long-term benefits for your liver and overall health.
#1 Current Management of Alcohol-Associated Liver Disease â Gastroenterology & Hepatology
https://www.gastroenterologyandhepatology.net/archives/november-2020/current-management-of-alcohol-associated-liver-disease/
Given the rising incidence of ALD and associated mortality, it is imperative to identify the underlying factors driving these trends, beginning with behaviors related to alcohol use. […] Based on dietary guidelines published by the US Department of Health and Human Services, women should consume no more than 1 alcohol-containing drink in a single day, and men should consume no more than 2 drinks in a single day. […] The frequency of alcohol consumption also affects the degree of liver disease and associated mortality. […] It is imperative that excessive alcohol use be identified early in patients at increased risk for ALD. […] According to the US Preventive Services Task Force (USPSTF), screening for unhealthy alcohol use accompanied by a brief intervention should be routine protocol in the primary care setting. […] The mainstay of management for acute AH is alcohol abstinence and managing any secondary complications related to cirrhosis or acute liver injury. […] Abstinence from alcohol is the primary method of preventing further liver damage or complications post-LT.
#1 Alcoholic liver disease: Symptoms, treatment, and causes
https://www.medicalnewstoday.com/articles/215638
To prevent alcoholic liver disease and other conditions linked to the consumption of alcohol, doctors advise people to follow National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines. […] The guidelines classify moderate drinking up to one drink a day for females, and up to two drinks for males, and only over the age of 21 years. […] The NIAAA defines binge drinking as five or more alcoholic drinks for males or four or more alcoholic drinks for females on the same occasion, on at least 1 day in the past month.
#1 Public health policies and alcohol-related liver disease
https://pmc.ncbi.nlm.nih.gov/articles/PMC7005647/
Alcohol-related liver disease (ALD) represents a major public health problem worldwide. Establishing effective public health policies is therefore mandatory to reduce the burden of ALD. Since the 90s, major public health institutions and governments have developed a variety of policies in order to reduce the harm caused by excessive drinking. These policies encompass multiple factors, from pricing and taxation to advertising regulation. Measures focused on taxation and price regulation have been shown to be the most effective at reducing alcohol-related mortality. […] Major public health institutions have been working to develop an array of public health policies aimed at reducing excessive and harmful alcohol use and thereby its detrimental effects on health. […] Taxation and price regulation are the most effective measures to reduce alcohol-related mortality, although the effect varies across different countries.
#1 Public health policies and alcohol-related liver disease
https://pmc.ncbi.nlm.nih.gov/articles/PMC7005647/
Public policies should therefore focus on preventing excessive alcohol drinking. […] The development of ALD requires excessive alcohol intake, so it is conceivable that policies that reduce the rate of hazardous drinking will positively influence the burden of ALD. […] Increasing alcoholic beverage taxes and minimum unit pricing (MUP) are the major pricing policies. Both have proven to have an impact on ALD burden. […] The other major pricing policy is MUP. […] The impact of youth-focused policies on the prevalence of ALD is unknown and deserves investigation. […] Another group of policies are focused on restricting physical access to alcohol, usually by legislating on the hours and days of sale and the density of alcohol outlets. […] Regulating advertising and promotion of alcohol beverages is a very controversial topic.
#1 Public health policies and alcohol-related liver disease
https://pmc.ncbi.nlm.nih.gov/articles/PMC7005647/
The latest EASL guidelines on ALD recommend a ban on alcohol advertising and marketing. […] The combined effect of different types of policy measures on the prevalence of heavy alcohol drinking and ALD burden is not well known. […] Effective public health measures are needed to reduce the burden of ALD.
#1 Alcohol-related liver disease study in JAMA | Queen’s University Gazette
https://www.queensu.ca/gazette/stories/new-and-alarming-trends-alcohol-related-liver-disease
To combat this growing public health crisis, Dr. Flemming advocates for a multi-pronged approach that focuses on education, prevention and the development of clinical trials and observational studies that apply a sex or gender-based methodologies. […] Primary prevention methods focus on educating the public about the risks of alcohol on the liver and implementing policies that address behaviours that lead to AH before it develops. This could include actions such as clearly labelling alcohol products in a similar fashion to nutritional information on food. Doing so could help consumers make more informed decisions about what they are consuming and avoid high-sugar alcoholic beverages. […] Secondary prevention methods such as early identification and intervention are also key to preventing further damage. Dr. Flemming stresses the importance of screening for alcohol use disorder in primary care settings, which could help identify individuals at risk before liver damage becomes severe.
#1 UCF Physicians Find Alternative Treatment Option for Alcohol-Related Liver Disease | University of Central Florida News
https://www.ucf.edu/news/ucf-physicians-find-alternative-treatment-option-for-alcohol-related-liver-disease/
Two UCF-trained physicians who are dedicating their careers to addiction medicine and digestive health are receiving national attention for their discovery that an off-label medicine could help patients with alcohol-related liver disease. […] The physician researchers hope that their findings will encourage more doctors to consider using gabapentinoids to treat patients with alcohol use dependency before they suffer significant liver damage. […] Both physicians said awareness is key to addressing alcohol use disorder and its serious damage to health. […] When education and risk awareness of the dangers of alcohol misuse goes up, usage tends to go down, Henriquez says. Thats why we need to put an emphasis on education and treatment. […] Each physician should review patients holistically at an individual level, considering their chronic medical problems and preferences while weighing the risks and benefits, Henriquez says.
#1 Alcoholic liver disease – UF Health
https://ufhealth.org/conditions-and-treatments/alcoholic-liver-disease
Talk openly to your provider about your alcohol intake. The provider can counsel you about how much alcohol is safe for you.
#1 Alcoholic Hepatitis (Alcohol-Associated Hepatitis) Treatment & Management: Approach Considerations, Cessation of Alcohol Intake, Diet and Nutritional Support
https://emedicine.medscape.com/article/170539-treatment
The 2019 American Association for the Study of Liver Diseases (AASLD) practice guidance recommends that all patients seen in primary care and gastroenterology/hepatology clinics, as well as all emergency department patients and hospital inpatients be screened for alcohol use using validated questionnaires. Patients engaged in hazardous drinking should be offered counseling, pharmacotherapy, and referral to treatment. […] Cessation of alcohol use is the mainstay of treatment for alcoholic hepatitis. The 2019 American Association for the Study of Liver Diseases (AASLD) alcoholic-associated liver disease guideline states that abstinence should be enjoined on patients with alcoholic hepatitis to improve long-term prognosis. […] In general, alcoholic hepatitis resolves or improves greatly following 6-12 months of alcohol abstinence, and continued improvement may be observed for several years. […] Patients should be referred to a program of rehabilitation and support, and they should be strongly encouraged to attend. Also, patients should be fully informed regarding the serious potential health consequences of continued ethanol use.
#1 Alcohol-Related Liver Disease – Hepatic and Biliary Disorders – Merck Manual Professional Edition
https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/alcohol-related-liver-disease/alcohol-related-liver-disease
The AASLD recommends using the Alcohol Use Disorders Inventory Test (AUDIT) if excessive alcohol use is suspected. […] General management emphasizes supportive care. A nutritious diet and vitamin supplements (especially B vitamins) are important during the first few days of abstinence. […] Severe acute alcoholic hepatitis commonly requires hospitalization, often in an intensive care unit, to facilitate enteral feeding (which can help manage nutritional deficiencies) and to manage specific complications (eg, infection, bleeding from esophageal varices, specific nutritional deficiencies, Wernicke encephalopathy, Korsakoff psychosis, electrolyte abnormalities, portal hypertension, ascites, portosystemic encephalopathy). […] Liver transplantation for alcohol-associated cirrhosis should be considered for all patients with decompensated liver disease (ascites, spontaneous bacterial peritonitis, variceal bleeding, hepatic encephalopathy) despite abstinence.
#1 Alcoholic Cirrhosis: Symptoms, Causes, Treatment, & Prevention | Zinnia Health
https://zinniahealth.com/substance-use/alcohol/alcoholic-cirrhosis
Alcoholic cirrhosis is a serious condition that affects heavy drinkers, but preventive measures can significantly reduce the risk of its development. Implementing effective strategies is crucial for promoting liver health and preventing the progression of liver disease. […] The primary preventive measure for alcoholic cirrhosis is moderating alcohol intake. Following established guidelines for moderate alcohol consumption can help protect the liver. For men, moderate drinking is defined as up to two drinks per day, while for women, it is up to one drink per day. […] Routine liver health checkups are essential for early detection and intervention. Regular monitoring, including liver function tests and imaging studies, enables healthcare professionals to assess liver health and identify any signs of developing cirrhosis.
#1
https://link.springer.com/article/10.1007/s40265-023-01939-9
Abstinence from alcohol is the cornerstone of treatment and should be recommended to all patients with ALD. Abstinence reduces the risk of hepatic decompensation and death in both compensated and decompensated cirrhosis patients. […] In patients with ALD, the combination of comprehensive medical care and psychosocial interventions are more likely to result in abstinence, and integrated care approaches are associated with better outcomes. […] Provision of behavioural treatment can be through brief interventions, motivational interviewing, cognitive behavioural therapy (CBT) or motivational enhancement therapy. CBT has the most consistent evidence for increasing abstinence in ALD, although data are limited. […] Testing for biomarkers of alcohol consumption can aid in diagnosis and follow-up of ALD by providing objective information about alcohol intake, in addition to self-report.
#1 Preventive Strategies in Chronic Liver Disease: Part I. Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise | AAFP
https://www.aafp.org/pubs/afp/issues/2001/1101/p1555.html
Chronic liver disease is the 10th leading cause of death in the United States. Preventive care can significantly reduce the progression of liver disease. Alcohol and hepatitis C virus are synergistic in hastening the development of cirrhosis; therefore, patients with hepatitis C infection should abstain from alcohol use. […] Abstinence is the most important measure in keeping chronic liver disease from progressing to cirrhosis. […] Strong evidence supports vaccination against hepatitis A and B viruses in patients with chronic liver disease. […] Complete abstinence from alcohol […] Avoidance of hepatotoxic medications, especially nonsteroidal anti-inflammatory drugs […] Measures that can be effective in preventing the progression of chronic liver disease to cirrhosis are summarized.
#1 How to Cleanse Your Liver from Alcohol Use | What You Should Know
https://www.therecoveryvillage.com/alcohol-abuse/repair-liver-alcohol-use/
There are several things you can do to repair your liver damage from alcohol most importantly to stop drinking. […] Alcoholic fatty liver treatment mainly relies on changes to your lifestyle. These changes can include: Quitting alcohol completely, Eating a healthy diet, Weight loss, if you are overweight, Exercise, which may reduce the amount of fat in the liver. […] Getting vaccinations such as hepatitis A, hepatitis B, pneumonia, and your yearly influenza (flu) shot will not treat AFLD but may help prevent more serious conditions from occurring later. […] Alcoholic hepatitis treatment involves stopping the use of alcohol and supporting the liver as it heals. Alcohol cessation is a crucial part of the initial treatment because as long as alcohol is used, there will be more inflammation.
#1 Protecting persons at-risk of viral hepatitis and alcohol-related liver disease during the pandemic and beyond: mitigating the impact of coronavirus disease 2019 on liver health | Published in Journal of Global Health Reports
https://www.joghr.org/article/24940-protecting-persons-at-risk-of-viral-hepatitis-and-alcohol-related-liver-disease-during-the-pandemic-and-beyond-mitigating-the-impact-of-coronavirus-d
Internet-based counselling and education services can be used to reach people at risk of developing AUD. […] Social distancing measures will remain in place for some time creating a new normal and operational change to NSP are needed. […] Needle and syringe services and addiction treatment units can be designated as essential services by health departments, which ensures the venues still being open, staff in place for consultation, and enough budget available to maintain supplies. […] Due to the possibility of an outbreak that could further disrupt the health system or high mortality from vaccine-preventable diseases, countries shall label routine immunization services as a priority health service. […] Because of the immunocompromised status of persons with liver disease, secondary infections, hepatic encephalopathy, and upper gastrointestinal bleeding are expected to increase and intense surveillance and treatment are needed for these patients. […] The community-based health workforce has strong ties with community actors and had significant success stories in disease prevention, particularly in low-and middle-income countries.
#1 Alcohol-related Liver Disease > Fact Sheets > Yale Medicine
https://www.yalemedicine.org/conditions/alcohol-related-liver-disease
The best treatment for ALD, regardless of the stage of the disease, is abstinence from alcohol. […] However, if someone drinks heavily and/or regularly, it can be difficult to stop and it may be unsafe to do so without medical guidance. […] People who have developed alcohol-related hepatitis and alcohol-related cirrhosis are often malnourished, which can lead to worse health outcomes. Therefore, its vital for those with any stage of ALD to maintain a healthy diet. […] For patients with severe alcohol-related hepatitis or severe alcohol-related cirrhosis who arent helped by other therapies, liver transplantation may be an option. […] To be considered for a liver transplant, patients must remain abstinent from alcohol prior to transplantation surgery. The purpose of this is to ensure that patients are able to maintain abstinence and are likely to remain abstinent after the transplant surgery.
#1 How to Prevent & Treat Alcohol-Related Liver Disease
https://www.bajajallianz.com/blog/wellness/understanding-alcohol-related-liver-disease.html
Excessive alcohol consumption over time can cause serious health problems, especially for the liver. […] However, with early detection, fatty liver treatment, and lifestyle changes like quitting alcohol, its possible to prevent further damage and improve liver health. […] Recognising symptoms and seeking timely treatment is crucial to preventing irreversible liver damage. […] Identifying these symptoms early and seeking medical attention can slow down the progression of alcoholic liver disease, especially when paired with lifestyle modifications such as quitting alcohol. […] Each stage of alcoholic liver disease indicates worsening damage to the liver, making early intervention critical for recovery and management. […] This is the most critical step in managing alcoholic liver disease. Stopping alcohol consumption can reverse damage in the early stages and prevent further harm.
#1
https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/treatment/
Successful treatment for alcohol-related liver disease (ARLD) often depends on whether someone is willing to stop drinking alcohol and make changes to their lifestyle. […] Treatment for ARLD involves stopping drinking alcohol. This is known as abstinence, which can be vital depending on what stage the condition is at. […] If you have a more serious form of ARLD (alcoholic hepatitis or cirrhosis) lifelong abstinence is recommended. […] This is because stopping drinking is the only way to prevent your liver damage getting worse and potentially stop you dying of liver disease. […] Nevertheless, if you have alcohol-related cirrhosis or alcoholic hepatitis and do not stop drinking, no medical or surgical treatment can prevent liver failure. […] Once you have stopped drinking, you may need further treatment to help ensure you do not start drinking again.
#1
https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/treatment/
If psychological therapy alone is not effective, you may also need medicine to help you abstain from alcohol, such as: acamprosate, disulfiram, naltrexone. […] Many people with alcohol dependence find it useful to attend self-help groups to help them stop drinking. […] Your GP can advise you on a suitable diet or, in some cases, refer you to a dietitian. […] A liver transplant may be considered if you commit to not drinking alcohol for the rest of your life.
#1 How Do I Manage Alcohol Use Disorder in Hepatology Clinic? | AASLD
https://www.aasld.org/liver-fellow-network/core-series/clinical-pearls/how-do-i-manage-alcohol-use-disorder-hepatology
First line medications for AUD include naltrexone and acamprosate. […] Acamprosate is renally metabolized and has been effective for AUD treatment in one study in patients with cirrhosis. […] Naltrexone is not well-studied in patients with chronic liver disease, but can be considered in patients with compensated disease. […] Baclofen is the best-studied medication for AUD in chronic liver disease and has demonstrated in patients with cirrhosis. […] Disulfiram should be avoided in patients with chronic liver disease due to risk of hepatotoxicity and has fallen out of favor due to poor adherence.
#1 How Do I Manage Alcohol Use Disorder in Hepatology Clinic? | AASLD
https://www.aasld.org/liver-fellow-network/core-series/clinical-pearls/how-do-i-manage-alcohol-use-disorder-hepatology
Baclofen is a GABAB agonist and although not FDA-approved for the treatment of AUD, is the most well-studied medication for treating AUD in patients with ALD. […] Acamprosate is an FDA-approved medication for treatment of AUD. […] Disulfiram, an acetyl-aldehyde dehydrogenase inhibitor, is an FDA-approved medication for AUD, however its use has been limited due to low adherence in patients. […] Naltrexone is an opioid receptor antagonist and is one of the most effective medications available for the treatment of AUD. […] Gabapentin is structurally similar to GABA and binds to voltage-gated calcium channels in the brain. […] Topiramate is FDA-approved for the treatment of seizures, and increases GABA activity and inhibits glutamate activity in the brain. […] Varenicline is a partial nicotinic receptor agonist, and has been highly successful for tobacco cessation.
#1 How Do I Manage Alcohol Use Disorder in Hepatology Clinic? | AASLD
https://www.aasld.org/liver-fellow-network/core-series/clinical-pearls/how-do-i-manage-alcohol-use-disorder-hepatology
E. This patient has evidence of decompensated cirrhosis and impaired synthetic function. Although not FDA-approved for the treatment of alcohol use disorder, baclofen can be used off-label for treatment of alcohol use disorder and has been safe and effective for treating alcohol use disorder in patients with cirrhosis. […] Acamprosate is an FDA-approved medication for the treatment of alcohol use disorder and is primarily renally metabolized. […] Disulfiram has been associated with drug-induced liver injury, and naltrexone is hepatically metabolized. These medications should be avoided if better-studied alternatives are available. […] The majority of the evidence base for medical treatment of AUD is derived from studies of patients without known underlying liver disease. As such, the safety profile and pharmacodynamics of some of these medications are not well-understood in patients with cirrhosis.
#1 Alcohol-Related Liver Disease (ARLD): Causes & Symptoms
https://www.recoveryatlanta.com/alcohol-related-liver-disease/
Alcohol rehabilitation is typically the most important step once you are off alcohol. […] Maintaining a balanced diet can help support liver health and improve ARLD symptoms more quickly once you stop drinking. […] Medications are necessary for someone with serious symptoms or complications associated with ARLD. […] In cases of advanced cirrhosis, a liver transplant may be the only life-saving option. […] Professional alcohol addiction treatment is the key to avoiding the complications ARLD can cause. Stopping alcohol will allow your liver to recover as much as possible, decreasing the risk of serious complications.
#1 Alcohol-Related Liver Disease (ARLD): Causes & Symptoms
https://www.recoveryatlanta.com/alcohol-related-liver-disease/
Stopping alcohol is essential to preventing and treating ARLD. Alcohol is the only cause of ARLD, and abstaining from alcohol use will prevent further ARLD from developing. […] While abstinence from alcohol is the cornerstone of ARLD management, this typically requires professional intervention, as the heavy drinking that causes ARLD is often linked to addiction. Treating alcohol addiction ultimately is the main intervention needed to prevent the progression of ARLD. […] Managing alcohol withdrawal symptoms is a critical aspect of maintaining abstinence. Alcohol withdrawal can be quite dangerous, and it is important to have medical intervention and support during the withdrawal. […] Relapse prevention is a vital part of sustaining long-term abstinence and mitigating the risk of ARLD progression.
#1 Alcohol-related Liver Disease > Fact Sheets > Yale Medicine
https://www.yalemedicine.org/conditions/alcohol-related-liver-disease
The treatment of alcohol-related liver disease requires a multidisciplinary approach, says Dr. Haque. Our team at Yale Medicine includes experts in liver diseases, addiction medicine/psychiatry, nutrition, and liver transplantation to provide a comprehensive, individualized, and evidence-based treatment plan for each patient at any stage of alcohol-related liver disease.
#1 Alcohol-related liver disease | NHS inform
https://www.nhsinform.scot/illnesses-and-conditions/stomach-liver-and-gastrointestinal-tract/alcohol-related-liver-disease/
Many people with alcohol dependence find it useful to attend self-help groups to help them stop drinking. […] Avoiding salty foods and not adding salt to foods you eat can reduce your risk of developing swelling in your legs, feet and abdomen (tummy) caused by a build-up of fluid. […] Your GP can advise you on a suitable diet or, in some cases, refer you to a dietitian.
#1 Alcoholic Hepatitis: Diagnosis and Management | AAFP
https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html
Abstinence from alcohol is the mainstay of treatment. Clinicians should counsel all patients on alcohol cessation, offer medications for alcohol use disorder when appropriate, and consider early consultation with a substance abuse counselor, social worker, and/or psychiatrist, depending on institutional resources. […] Nutritional support can include low-volume intravenous fluids for dehydration; intravenous or oral thiamine to decrease risk of Wernicke encephalopathy; and supplemental folate, vitamin B6, vitamin B12, and zinc for common vitamin deficiencies. Daily energy intake of 35 to 40 kcal per kg of body weight and daily protein intake of 1.2 to 1.5 g per kg of body weight are recommended. […] Given the high rate of concomitant infections in patients with alcoholic hepatitis, it is reasonable to administer broad-spectrum empiric antibiotics while awaiting culture results.
#1 Alcoholic Liver Disease | UCSF Department of Surgery
https://hpbsurgery.ucsf.edu/condition/alcoholic-liver-disease
Abstinence from alcohol is vital to prevent further liver injury, scarring, and possibly liver cancer; it appears to benefit patients at each stage of the disease. […] Although only a few studies have looked specifically at the effects of abstinence on the progression of ALD, virtually every one has shown that abstaining from alcohol is beneficial. […] Stopping smoking and maintaining a healthy weight are two more measures patients can take to reduce or prevent further liver injury. […] To prevent these deficiencies, clinicians should provide alcoholics with a balanced diet. […] Clinicians recommend that all alcoholics undergoing treatment receive 50 milligrams of thiamine per day. […] For treatment to be most successful, clinicians recommend that alcoholic patients abstain from drinking alcohol at least 6 months prior to beginning interferon therapy. […] Treatment strategies for ALD include lifestyle changes to reduce alcohol consumption, cigarette smoking, and obesity; nutritional therapy; pharmacological therapy; and possibly liver transplantation (in case of cirrhosis).
#1
https://link.springer.com/article/10.1007/s40265-023-01939-9
While alcohol cessation is the most effective way to limit ongoing liver damage and reduce the complications of ALD, several aspects of care require ongoing attention. […] Patients with AAC are at increased risk of developing HCC and benefit from 6-monthly surveillance with abdominal ultrasound with or without serum -fetoprotein. […] Chronic alcohol consumption with or without ALD can lead to malnutrition, which is associated with poorer outcomes in chronic liver disease. Therefore, patients with ALD should be regularly assessed for malnutrition by a dietitian, and if identified, be prescribed nutritional supplementation of calories, protein and vitamins.
#1 Management of alcohol-associated steatosis and alcohol-associated cirrhosis – UpToDate
https://www.uptodate.com/contents/management-of-alcohol-associated-steatosis-and-alcohol-associated-cirrhosis
Abstinence is required for placement on the liver transplantation waiting list at most transplantation centers. […] Avoidance of alcohol remains the cornerstone of treatment for all patients with ALD because alcohol use is an important risk factor for disease progression. […] For patients with alcohol-associated cirrhosis, abstinence decreases the risk of liver-related complications.
#1 Alcoholic Hepatitis: Diagnosis and Management | AAFP
https://www.aafp.org/pubs/afp/issues/2022/0400/p412.html
There is growing support for early liver transplantation in some patients with severe alcoholic hepatitis, rather than requiring six months of alcohol abstinence and engagement in alcohol cessation counseling. […] Ongoing treatment of alcohol use disorder is paramount to long-term survival of patients with alcoholic hepatitis. Alcohol rehabilitation is associated with a decrease in hospital readmission, relapse, and mortality.
#1 As alcoholic liver disease rises, how do we treat it more effectively?
https://harvardpublichealth.org/equity/how-we-treat-alcohol-related-liver-disease-is-unfair-time-for-change/
Michaels story is not unique. […] To prevent deaths, we must invest in better disease prevention and treatment. That includes changing the rules around who gets a liver transplant, and integrating addiction treatment into comprehensive transplant care. […] The answer lies in adopting a better approach to managing alcohol use disorderboth to prevent the development of liver disease in the first place, and improve health outcomes for patients who do progress to liver disease and need a transplant. […] First, we must change the eligibility rules for transplant. […] The strict rules surrounding liver transplants are in place to select patients who are unlikely to start drinking again post-transplant, as a return to heavy drinking risks severe damage to a transplanted liver. […] However, an arbitrary period of abstinence shouldnt be a prerequisite for transplant eligibility, and a relapse shouldnt automatically disqualify a patient from getting a liver transplant.
#1 Preventing Alcohol Relapse After Liver Transplant, with Wei Zhang, MD, PhD
https://www.hcplive.com/view/preventing-alcohol-relapse-after-liver-transplant-with-wei-zhang-md-phd
Zhang describes the importance of multidisciplinary care for preventing alcohol relapse post-transplant, citing success from Mass Generals LIFT Clinic. […] In December 2022, he and a group of colleagues from Massachussetts General Hospital established the Long-term Individualized Follow-up after Transplant (LIFT) Clinic, a multidisciplinary program involving a hepatologist, a psychiatrist, a social worker, and a case manager to assist in the prevention and management of alcohol relapse in high-risk liver transplant recipients. […] We try to prevent them from relapsing, because once they relapse, they lose some of the incentives after transplant because they already got a transplant, Zhang explained to HCPLive. […] Loking ahead, Zhang points to the importance of being mindful of relapse in patients considered to be low risk, citing a scenario he encountered with a patient who was sober for 5 years but experienced a severe relapse.
#1 Preventing Alcohol Relapse After Liver Transplant, with Wei Zhang, MD, PhD
https://www.hcplive.com/view/preventing-alcohol-relapse-after-liver-transplant-with-wei-zhang-md-phd
Now, the LIFT Clinic has expanded to include all patients who have alcohol as a contributing factor to their liver disease. […] If we find that they have very low risk, we could see them in a longer interval, but if we find any high risk factors in those patients, we start to follow them very closely, he explained.
#1 Managing medicines in alcohol-associated liver disease: a practical review
https://australianprescriber.tg.org.au/articles/managing-medicines-in-alcohol-associated-liver-disease-a-practical-review.html
People with alcohol-associated liver disease often take medicines to manage complications of liver disease and comorbidities. However, patients may be at increased risk of drug-related harm. […] Regular medication review is essential to ensure ongoing appropriateness and safety. […] Optimising medicines to manage complications of liver disease and comorbidities can be difficult due to […] Primary care clinicians are ideally placed to improve medication safety by reviewing and monitoring a patients medicines and reducing use of potentially inappropriate medicines. […] Intervention to support abstinence is essential, as cessation of drinking reduces the risk of liver disease progression, and cirrhosis-related complications, and it improves clinical outcomes at all stages. […] In addition to psychosocial treatments, pharmacotherapy may be prescribed to support abstinence.
#1 Alcoholic hepatitis – Symptoms and causes – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/alcoholic-hepatitis/symptoms-causes/syc-20351388
You might reduce your risk of alcoholic hepatitis if you: […] Drink alcohol in moderation, if at all. For healthy adults, moderate drinking means up to one drink a day for women and up to two drinks a day for men. The only certain way to prevent alcoholic hepatitis is to avoid all alcohol. […] Protect yourself from hepatitis C. Hepatitis C is a liver disease caused by a virus. Without treatment, it can lead to cirrhosis. If you have hepatitis C and drink alcohol, you’re far more likely to get cirrhosis than if you don’t drink. […] Check before mixing medicines and alcohol. Ask your healthcare professional if it’s safe to drink alcohol when taking your prescribed medicines. Read the warning labels on medicines you can get without a prescription. Don’t drink alcohol when taking medicines that warn against drinking alcohol while taking them. This includes pain relievers such as acetaminophen (Tylenol, others).
#1 Managing medicines in alcohol-associated liver disease: a practical review
https://australianprescriber.tg.org.au/articles/managing-medicines-in-alcohol-associated-liver-disease-a-practical-review.html
These medicines have modest efficacy and most have limited or no published safety data in people with cirrhosis and should only be considered under specialist guidance. […] Doctors, nurses, and pharmacists in the primary care setting have an important role in the management of patients with alcohol-associated liver disease. In addition to supporting abstinence, optimising medicine use is imperative to improve outcomes and minimise harm.
#1 Alcohol-related liver disease study in JAMA | Queen’s University Gazette
https://www.queensu.ca/gazette/stories/new-and-alarming-trends-alcohol-related-liver-disease
For those who have already developed AH, the focus becomes tertiary prevention strategies aimed at managing and minimizing the impact of a disease or condition once it has already caused liver damage. She emphasizes that early intervention can reduce the risk of further liver damage and dramatically improve patient outcomes.
#1 Alcohol related liver disease (ALD) — Irish Liver Foundation
https://www.liverfoundation.ie/alcohol-related-liver-disease-ald
Over the course of a 7-day week, individuals should not consume more than: […] Alcohol consumption should be spread out over the course of the week and you should have several alcohol-free days, not consuming more than 3 pints or 6 small glasses of wine in one day. […] If you stop drinking alcohol completely for a prolonged period of time (months to years) the liver can heal itself and recover. […] At all stages however, abstinence from alcohol offers the best outcomes. […] The main goals of management are: 1) Achieving abstinence from alcohol and maintaining it […] The best treatment for ALD is alcohol abstinence. […] Maintaining a healthy lifestyle and reducing your risk factors is another means of protecting your liver. […] For persons struggling to achieve abstinence from alcohol, there are medications available to help with this such as Campral (Acamprosate), Vivitrol (Naltrexone), and other options. […] Alcohol-related liver disease is one of the leading condition for which liver transplants are performed in Ireland. […] You will have the most important role in your management of alcohol-related liver disease as alcohol cessation is the mainstay of treatment and prevention.
#2 Public health policies and alcohol-related liver disease
https://pmc.ncbi.nlm.nih.gov/articles/PMC7005647/
Public policies should therefore focus on preventing excessive alcohol drinking. […] The development of ALD requires excessive alcohol intake, so it is conceivable that policies that reduce the rate of hazardous drinking will positively influence the burden of ALD. […] Increasing alcoholic beverage taxes and minimum unit pricing (MUP) are the major pricing policies. Both have proven to have an impact on ALD burden. […] The other major pricing policy is MUP. […] The impact of youth-focused policies on the prevalence of ALD is unknown and deserves investigation. […] Another group of policies are focused on restricting physical access to alcohol, usually by legislating on the hours and days of sale and the density of alcohol outlets. […] Regulating advertising and promotion of alcohol beverages is a very controversial topic.
#2 Public health policies and alcohol-related liver disease
https://pmc.ncbi.nlm.nih.gov/articles/PMC7005647/
Alcohol-related liver disease (ALD) represents a major public health problem worldwide. Establishing effective public health policies is therefore mandatory to reduce the burden of ALD. Since the 90s, major public health institutions and governments have developed a variety of policies in order to reduce the harm caused by excessive drinking. These policies encompass multiple factors, from pricing and taxation to advertising regulation. Measures focused on taxation and price regulation have been shown to be the most effective at reducing alcohol-related mortality. […] Major public health institutions have been working to develop an array of public health policies aimed at reducing excessive and harmful alcohol use and thereby its detrimental effects on health. […] Taxation and price regulation are the most effective measures to reduce alcohol-related mortality, although the effect varies across different countries.
#2
https://journals.lww.com/ajg/abstract/9900/prevention_of_alcohol_associated_liver_disease.1651.aspx
Alcohol-associated liver disease (ALD) is the leading cause of morbidity, disease adjusted life-years lost, and mortality worldwide. The significant burden and cost to the healthcare systems from ALD is largely preventable, given that alcohol use is the most important determinant of risk and severity of ALD. […] In this article, we will review the emerging evidence for public health policies (minimum unit price of alcohol, limiting or banning alcohol advertising), aiming to reduce the availability of alcohol at the population level (primary prevention), preventing ALD especially advanced form of cirrhosis in at risk individuals (secondary prevention), and improving liver outcomes and long-term survival in patients with advanced ALD of cirrhosis and / or alcohol-associated hepatitis (tertiary prevention). […] We will highlight the critical role of clinicians in promoting the public health policies, widespread screening for AUD and for ALD, and integrating liver with addiction care for patients with ALD.
#2 Alcoholic liver disease: MedlinePlus Medical EncyclopediaLock
https://medlineplus.gov/ency/article/000281.htm
Talk openly to your provider about your alcohol intake. The provider can counsel you about how much alcohol is safe for you. […] Some things you can do to help take care of your liver disease are: Stop drinking alcohol. Eat a healthy diet that is low in salt. Get vaccinated for diseases such as influenza, hepatitis A and hepatitis B, and pneumococcal pneumonia. Talk to your provider about all medicines you take, including herbs and supplements and over-the-counter medicines.
#2 Alcohol-Related Liver Disease – Hepatic and Biliary Disorders – Merck Manual Professional Edition
https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/alcohol-related-liver-disease/alcohol-related-liver-disease
Abstinence is the mainstay of treatment; it prevents further damage from alcohol-related liver disease and thus prolongs life. […] Patients with alcohol-related liver disease or other liver diseases, in particular nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, viral hepatitis, and hemochromatosis, or any drinking that leads to negative consequences, should be counseled that there is no safe level of drinking and that they should abstain. […] The American Association for the Study of Liver Diseases (AASLD) recommends that patients receiving care in primary care and gastroenterology/hepatology outpatient clinics, emergency departments, and in hospitals (as inpatients) be screened routinely for alcohol use with validated questionnaires. Brief intervention, pharmacotherapy, and referral to treatment should be offered to patients engaged in hazardous drinking (ie, heavy or binge drinking).
#2 Prevention and Treatment | Division of Gastroenterology
https://gastro.uw.edu/research/carr-lab/prevention-and-treatment
The first treatment line is to stop drinking alcohol altogether. […] In the early stages of liver disease, stop drinking will allow the liver to heal itself. […] Things that will help you take care of liver disease are: Stop drinking alcohol […] Get vaccinated for diseases such as influenza, hepatitis A and hepatitis B, and pneumococcal pneumonia.
#2 Management of alcohol-associated steatosis and alcohol-associated cirrhosis – UpToDate
https://www.uptodate.com/contents/management-of-alcohol-associated-steatosis-and-alcohol-associated-cirrhosis
Abstinence is required for placement on the liver transplantation waiting list at most transplantation centers. […] Avoidance of alcohol remains the cornerstone of treatment for all patients with ALD because alcohol use is an important risk factor for disease progression. […] For patients with alcohol-associated cirrhosis, abstinence decreases the risk of liver-related complications.
#2 Alcohol – Liver Foundation
https://liver.org.au/living-well/alcohol/
Stopping drinking can often reverse the liver damage. If the damage is severe, stopping drinking will prevent it from getting even worse. […] People with alcoholic hepatitis or alcoholic cirrhosis should stop drinking completely. If they donât, they are likely to develop life-threatening health problems. […] The first step is to talk to your doctor. There is plenty they can do to help you stop drinking.
#2 Alcohol-related liver disease | NHS inform
https://www.nhsinform.scot/illnesses-and-conditions/stomach-liver-and-gastrointestinal-tract/alcohol-related-liver-disease/
The most effective way to prevent ARLD is to stop drinking alcohol or stick to the low-risk drinking guidelines. […] Even if you’ve been a heavy drinker for many years, reducing or stopping your alcohol intake will have important short- and long-term benefits for your liver and overall health. […] Treatment for ARLD involves stopping drinking alcohol. This is known as abstinence, which can be vital, depending on what stage the condition is at. […] If you have a more serious form of ARLD alcoholic hepatitis or cirrhosis life-long abstinence is recommended. This is because stopping drinking is the only way to prevent your liver damage getting worse and potentially stop you dying of liver disease. […] Once you’ve stopped drinking, you may need further treatment to help ensure you don’t start drinking again.
#2 How Do I Manage Alcohol Use Disorder in Hepatology Clinic? | AASLD
https://www.aasld.org/liver-fellow-network/core-series/clinical-pearls/how-do-i-manage-alcohol-use-disorder-hepatology
First line medications for AUD include naltrexone and acamprosate. […] Acamprosate is renally metabolized and has been effective for AUD treatment in one study in patients with cirrhosis. […] Naltrexone is not well-studied in patients with chronic liver disease, but can be considered in patients with compensated disease. […] Baclofen is the best-studied medication for AUD in chronic liver disease and has demonstrated in patients with cirrhosis. […] Disulfiram should be avoided in patients with chronic liver disease due to risk of hepatotoxicity and has fallen out of favor due to poor adherence.
#2 Alcohol-related liver disease | NHS inform
https://www.nhsinform.scot/illnesses-and-conditions/stomach-liver-and-gastrointestinal-tract/alcohol-related-liver-disease/
Many people with alcohol dependence find it useful to attend self-help groups to help them stop drinking. […] Avoiding salty foods and not adding salt to foods you eat can reduce your risk of developing swelling in your legs, feet and abdomen (tummy) caused by a build-up of fluid. […] Your GP can advise you on a suitable diet or, in some cases, refer you to a dietitian.